CIK 0001200375 · Non-accelerated filer<br>Smaller reporting company
CODEXIS, INC.
Sign in to watch- Ticker
- CDXS
- Exchange
- Nasdaq
- Industry
- Industrial Organic Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 710872999
- Phone
- 650-421-8100
- Business address
- 200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063
- Former names
- CODEXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,446
- in 3 filings
Net −$18,446. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | De Vre Raymond Director | Sale | −1,088 | $1.11 | $1K | 83,723 |
| 2026-10-12 | Erbez Georgia See Remarks | Sale | −6,335 | $1.36 | $9K | 60,475 |
| 2026-10-12 | MOORE ALISON President and CEO | Sale | −6,335 | $1.36 | $9K | 244,171 |
| 2026-06-17 | PARKER H STEWART Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-17 | Collins Cynthia Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-17 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-17 | Smith David V Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-17 | Singhvi Rahul Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-17 | Martinborough Esther Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-17 | DILLY STEPHEN GEORGE Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-17 | De Vre Raymond Director | Grant or award · Stock Option (Right to Buy) | +66,350 | 66,350 | ||
| 2026-06-11 | De Vre Raymond Director | Sale | −2,605 | $2.37 | $6K | 84,811 |
| 2026-02-24 | Lutz Stefan Chief Scientific Officer | Sale | −5,862 | $1.13 | $7K | 130,421 |
| 2026-02-23 | Lutz Stefan Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +316,100 | 316,100 | ||
| 2026-02-23 | MOORE ALISON President and CEO | Grant or award · Stock Option (Right to Buy) | +993,000 | 993,000 | ||
| 2026-02-23 | Erbez Georgia See Remarks | Grant or award · Stock Option (Right to Buy) | +316,100 | 316,100 | ||
| 2026-02-06 | Lutz Stefan Chief Scientific Officer | Sale | −2,492 | $1.31 | $3K | 136,283 |
| 2026-02-06 | Erbez Georgia See Remarks | Sale | −3,826 | $1.31 | $5K | 66,810 |
| 2026-02-06 | MOORE ALISON President and CEO | Sale | −3,826 | $1.31 | $5K | 250,506 |
| 2026-01-07 | Lutz Stefan CSO | Sale | −4,685 | $1.70 | $8K | 138,775 |
Page 1 of 36 · 712 trades